Executive announcements: Meditech, TeraRecon

TriMed Staff | | Health Imaging | Artificial Intelligence
Meditech has promoted Robert Gale to senior vice president, product development and Michelle O'Connor to the position of vice president, product development. Gale will serve in an advisory role over Meditech's development efforts and play a leading role in future special projects. O'Connor will have the primary responsibility for the direct management of the company's development efforts, as well as shaping Meditech's longer-term direction.

TeraRecon has promoted Jeffrey Sorenson to vice president of Aquarius sales, U.S. and Canada. Sorenson joined TeraRecon as Aquarius Zone sales manager for the midwest zone in September 2004. From there, he was promoted to director of Aquarius sales and business development, U.S. and Canada in January 2006, taking responsibility for management of the whole Aquarius sales team.

TriMed Staff

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.